Nvidia Corp vs Tilray Brands Inc — how do they compare? Nvidia Corp trades at $223.5 (market cap $5.45T), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: Nvidia Corp is far larger — about 9212.3× Tilray Brands Inc's market cap, and Nvidia Corp pays a 0.44% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| NVDA | TLRY | |
|---|---|---|
Market Cap | $5.45T | $591.60M |
Sector | Technology | Health |
52-Week High | $235.75 | $21.00 |
52-Week Low | $165.17 | $3.88 |
Enterprise Value | $5.43T | $758.73M |
Dividend Yield | 0.44% | — |
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $225.73, down 2.01% today, with a bullish technical signal from moving averages and support near $222. The company reported robust earnings beats in recent quarters, with Q3 2026 EPS expected at $2.47. Revenue surged to $130.50B in 2025, driving a net income margin of 63.66%, while valuation ratios like P/E of 28.54 reflect high growth expectations. Analysts maintain strong buy consensus amid AI-driven demand.
Outlook remains positive due to AI leadership and accelerating revenue, but risks include competition and market volatility. The stock offers significant upside to the $344.10 consensus target, though investors should monitor execution risks and macroeconomic headwinds.
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
Trailing returns across standard periods
Latest headlines on both assets
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →